naloxone presentation for idaho board of pharmacy 2
TRANSCRIPT
![Page 1: Naloxone presentation for Idaho Board of Pharmacy 2](https://reader036.vdocuments.us/reader036/viewer/2022062523/587802d01a28ab91178b7245/html5/thumbnails/1.jpg)
Idaho State Board of PharmacyNaloxone Overview
Robert S. ColeAda County Paramedics
![Page 2: Naloxone presentation for Idaho Board of Pharmacy 2](https://reader036.vdocuments.us/reader036/viewer/2022062523/587802d01a28ab91178b7245/html5/thumbnails/2.jpg)
Disclaimer
• Nothing to sell• No conflicts of interest.
“I'm just a poor boy, nobody loves me.He's just a poor boy from a poor family,”
![Page 3: Naloxone presentation for Idaho Board of Pharmacy 2](https://reader036.vdocuments.us/reader036/viewer/2022062523/587802d01a28ab91178b7245/html5/thumbnails/3.jpg)
Objectives• Background on Naloxone• Opioids on the streets• Naloxone on the Streets• Setting up Naloxone for Lay Persons• Vital Information for the Lay Person
Administering Narcan• Post-Narcan Care
cc: intropin - https://www.flickr.com/photos/49002399@N06
![Page 4: Naloxone presentation for Idaho Board of Pharmacy 2](https://reader036.vdocuments.us/reader036/viewer/2022062523/587802d01a28ab91178b7245/html5/thumbnails/4.jpg)
Background on Naloxone•Patented in 1961, and rapidly adopted in emergency medicine and EMS by the mid 70’s. • Patent Expired• On the WHO list of essential medications•Currently, there are an estimated 16,000 deaths annually in the US attributed to Opoids• Likely under estimated•In 2014, FDA (Fast Tracked) approval for lay public/Non Medical responder formulations• IM: Auto Injector “Evzio”• IN: Narcan Nasal Spray
cc: VCU CNS - https://www.flickr.com/photos/40077485@N00
![Page 5: Naloxone presentation for Idaho Board of Pharmacy 2](https://reader036.vdocuments.us/reader036/viewer/2022062523/587802d01a28ab91178b7245/html5/thumbnails/5.jpg)
![Page 6: Naloxone presentation for Idaho Board of Pharmacy 2](https://reader036.vdocuments.us/reader036/viewer/2022062523/587802d01a28ab91178b7245/html5/thumbnails/6.jpg)
Basic information• Pure Opioid Antagonist• Works predominantly on the Mu Opioid receptors in the central
Nervous System– Very little effect on the other opioid receptors
• Clinical effect typically 20-40 minutes. – ½ live 30-80 minutes– Clinical effect shorter than many opioids
• Most effective when administered IV, IM, SQ, SL, and IO.– Wide dose range based on clinical situation for HCP– Limited dose range and routes for lay public (2-4 mg IV, IM)
• Limited inconclusive research on possible use in sepsis, and certain other CNS depressants.
![Page 7: Naloxone presentation for Idaho Board of Pharmacy 2](https://reader036.vdocuments.us/reader036/viewer/2022062523/587802d01a28ab91178b7245/html5/thumbnails/7.jpg)
![Page 8: Naloxone presentation for Idaho Board of Pharmacy 2](https://reader036.vdocuments.us/reader036/viewer/2022062523/587802d01a28ab91178b7245/html5/thumbnails/8.jpg)
Opioid Toxidrome
• The Opiate Toxidrome consists of:– Altered mental status – Miosis*– Unresponsiveness – Shallow respirations – Slow respiratory rate – Decreased bowel sounds – Hypothermia– Hypotension*
• * these symptoms are very subjective, and may not be present in polypharmacy overdoses.
KEY POINT: Miosis and Hypotension are not definitive for ruling in or ruling out a opioid overdose.
![Page 9: Naloxone presentation for Idaho Board of Pharmacy 2](https://reader036.vdocuments.us/reader036/viewer/2022062523/587802d01a28ab91178b7245/html5/thumbnails/9.jpg)
Opioids on the streets
• Shooting• Skin Popping• Muscle Popping• Chasing the dragon• Freebasing• Plugging and Shelving• Transdermal
![Page 10: Naloxone presentation for Idaho Board of Pharmacy 2](https://reader036.vdocuments.us/reader036/viewer/2022062523/587802d01a28ab91178b7245/html5/thumbnails/10.jpg)
So why do people overdose?
• IV opioid use• Poly-pharmacy Overdose• Returning to opioid use from abstinence – Jail?– Detox?
• The Weekend Warrior• Using opioids alone • New supply of Drug
![Page 11: Naloxone presentation for Idaho Board of Pharmacy 2](https://reader036.vdocuments.us/reader036/viewer/2022062523/587802d01a28ab91178b7245/html5/thumbnails/11.jpg)
According to the CDC
•Misuse of opioids accounts for 1000 ER visits a day in the US•Over 40,000 deaths per year (2014 stats) • Over 16,000 related to prescription opioids•Most common prescription opioid deaths:• Methadone• Oxycodone (such as OxyContin®)• Hydrocodone (such as Vicodin®)
cc: Anna & Michal - https://www.flickr.com/photos/97006177@N00
![Page 12: Naloxone presentation for Idaho Board of Pharmacy 2](https://reader036.vdocuments.us/reader036/viewer/2022062523/587802d01a28ab91178b7245/html5/thumbnails/12.jpg)
“Speed Balls”
![Page 13: Naloxone presentation for Idaho Board of Pharmacy 2](https://reader036.vdocuments.us/reader036/viewer/2022062523/587802d01a28ab91178b7245/html5/thumbnails/13.jpg)
Poly Pharmacy Opioid Situations
![Page 14: Naloxone presentation for Idaho Board of Pharmacy 2](https://reader036.vdocuments.us/reader036/viewer/2022062523/587802d01a28ab91178b7245/html5/thumbnails/14.jpg)
The New Opioid: Poly-Opioid Mixes
![Page 15: Naloxone presentation for Idaho Board of Pharmacy 2](https://reader036.vdocuments.us/reader036/viewer/2022062523/587802d01a28ab91178b7245/html5/thumbnails/15.jpg)
Key Points
•Narcan may not be enough• May not be effective• May not be only an opioid• May have been down too long• May need to redose
cc: jev55 - https://www.flickr.com/photos/52024976@N06
![Page 16: Naloxone presentation for Idaho Board of Pharmacy 2](https://reader036.vdocuments.us/reader036/viewer/2022062523/587802d01a28ab91178b7245/html5/thumbnails/16.jpg)
Naloxone on the Streets
![Page 17: Naloxone presentation for Idaho Board of Pharmacy 2](https://reader036.vdocuments.us/reader036/viewer/2022062523/587802d01a28ab91178b7245/html5/thumbnails/17.jpg)
Target Population
The target population for naloxone is persons who may have overdosed on opioids and whose respiratory drive
is at a depressed life-threatening level.
Naloxone is for depressed respirations, not depressed mental status.
Opiate use alone (without depressed respirations) does not merit the use of naloxone.
17cc: Bogdan Suditu - https://www.flickr.com/photos/8726888@N08
![Page 18: Naloxone presentation for Idaho Board of Pharmacy 2](https://reader036.vdocuments.us/reader036/viewer/2022062523/587802d01a28ab91178b7245/html5/thumbnails/18.jpg)
cc: c@rljones - https://www.flickr.com/photos/17149966@N00
![Page 19: Naloxone presentation for Idaho Board of Pharmacy 2](https://reader036.vdocuments.us/reader036/viewer/2022062523/587802d01a28ab91178b7245/html5/thumbnails/19.jpg)
Intranasal Naloxone
• Minimizes risk for blood borne pathogen exposure (no needle)
• May be administered rapidly and painlessly
• Onset of action is 3-5 minutes, peak effect is 12-20 minutes Protect naloxone from light
Avoid temperature extremes
19
![Page 20: Naloxone presentation for Idaho Board of Pharmacy 2](https://reader036.vdocuments.us/reader036/viewer/2022062523/587802d01a28ab91178b7245/html5/thumbnails/20.jpg)
Intranasal Naloxone
![Page 21: Naloxone presentation for Idaho Board of Pharmacy 2](https://reader036.vdocuments.us/reader036/viewer/2022062523/587802d01a28ab91178b7245/html5/thumbnails/21.jpg)
Intranasal Naloxone
![Page 22: Naloxone presentation for Idaho Board of Pharmacy 2](https://reader036.vdocuments.us/reader036/viewer/2022062523/587802d01a28ab91178b7245/html5/thumbnails/22.jpg)
Intranasal Naloxone
![Page 23: Naloxone presentation for Idaho Board of Pharmacy 2](https://reader036.vdocuments.us/reader036/viewer/2022062523/587802d01a28ab91178b7245/html5/thumbnails/23.jpg)
Intranasal Dose
•2-4 mg•1/2 of dose in each nostril
![Page 24: Naloxone presentation for Idaho Board of Pharmacy 2](https://reader036.vdocuments.us/reader036/viewer/2022062523/587802d01a28ab91178b7245/html5/thumbnails/24.jpg)
Intramuscular Naloxone
• Intramuscular likely more reliable– Needle Risk
• Lay Public Dose: 2-4 mg• Locations:– Any large muscle mass– Thigh– Upper Arm– Buttocks
![Page 25: Naloxone presentation for Idaho Board of Pharmacy 2](https://reader036.vdocuments.us/reader036/viewer/2022062523/587802d01a28ab91178b7245/html5/thumbnails/25.jpg)
Vital Information for the Lay Person Administering Narcan
•Call 911 first without delay•CPR takes priority OVER Naloxone• “Hands Only CPR is OK if no face mask•Naloxone often causes vomiting• Roll on side if not doing CPR• Keep airway clear•DON’T STOP CPR FOR NARCAN ADMINSITRATION
cc: US Army Africa - https://www.flickr.com/photos/36281822@N08
![Page 26: Naloxone presentation for Idaho Board of Pharmacy 2](https://reader036.vdocuments.us/reader036/viewer/2022062523/587802d01a28ab91178b7245/html5/thumbnails/26.jpg)
Post-Narcan Care• Roll on side if CPR is not
needed• If CPR is needed, do CPR until
the patient wakes up
cc: _cyrilvallee_ - https://www.flickr.com/photos/47448640@N00
![Page 27: Naloxone presentation for Idaho Board of Pharmacy 2](https://reader036.vdocuments.us/reader036/viewer/2022062523/587802d01a28ab91178b7245/html5/thumbnails/27.jpg)
In Closing• Narcan does not always work• Dose is 2-4 mg for lay public, IV or IN• Call 911 early as possible• CPR (If needed) as early as possible,
even if Narcan is given• Continue CPR (if needed) until the patient wakes up, or EMS directs otherwise.
cc: Leo Reynolds - https://www.flickr.com/photos/49968232@N00